Loading clinical trials...
Loading clinical trials...
The purpose of this study is to look at how Alpha-1-antitrypsin (AAT) deficiency and Cystic Fibrosis (CF) affect white blood cells in the lungs, called macrophages, and their ability to work.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Florida
NCT00500123 · Alpha-1 Antitrypsin Deficiency
NCT07152834 · Alpha 1-antitrypsin Deficiency (AATD)
NCT02796937 · Pulmonary Emphysema in Alpha-1 Antitrypsin Deficiency
NCT06405633 · Alpha-1 Antitrypsin Deficiency
NCT06677307 · Alpha-1 Anti-trypsin Deficiency, AATD
Shands at the University of Florida
Gainesville, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions